CoChat

Appropriateness of breast‐conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic‐based series

Open access
Robson, Mark, Svahn, Tiffany, McCormick, Beryl, Borgen, Patrick, A. Hudis, Clifford, Norton, Larry, Offit, Kenneth · 2005 · Cancer
Cited by 126

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Although BRCA1 and BRCA2 were identified in 1994 and 1995, respectively, to the authors' knowledge the optimal management of women with BRCA‐associated breast carcinoma remains incompletely defined. The current study evaluates the appropriateness of breast‐conserving therapy (BCT) in women with BRCA mutations. METHODS: Between May 1992 and October 2003, 87 female participants in genetic testing protocols were identified who 1) were found to have deleterious germline BRCA mutations and 2) reported a history of invasive breast carcinoma that was treated with wide local excision and radiation therapy. Clinical records were reviewed and follow‐up was updated. RESULTS: The 87 subjects underwent BCT for 95 invasive breast tumors (8 women received BCT for metachronous bilateral tumors). In all 95 treated breasts, the 5‐year and 10‐year probabilities of metachronous ipsilateral breast carcinoma (MIBC) were 11.2% and 13.6%, respectively. Among the 87 subjects, the 5‐year and 10‐year probabilities of metachronous contralateral breast carcinoma (CBC) after treatment of the index tumor were 11.9% and 37.6%. No clinical factors were identified that were associated with either MIBC or CBC, including the use of tamoxifen or chemotherapy. CONCLUSIONS: Women with BRCA‐associated breast carcinoma who undergo BCT appear to have risks of MIBC that are similar to those reported for young women without known mutations. The indications for unilateral mastectomy in this group of women should be the same as those for women with nonhereditary carcinoma. However, significant risks of CBC and possibly late MIBC may prompt the serious consideration of bilateral mastectomy as a preventive measure. Cancer 2005. © 2004 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.20728

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 24

  1. 10.1126/science.7545954 · DOI · Paper page
  2. 10.1038/378789a0 · DOI · Paper page
  3. 10.1053/srao.2002.35254 · DOI
  4. Foulkes WD, 1997, Germ‐line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer, Clin Cancer Res, 3, 2465
  5. 10.1016/S0167-8140(98)00023-1 · DOI
  6. 10.1093/jnci/91.24.2112 · DOI · Paper page
  7. 10.1200/JCO.2000.18.19.3360 · DOI · Paper page
  8. Pierce L, 2003, Ten‐year outcome of breast‐conserving surgery (BCS) and radiotherapy (RT) in women with breast cancer (BC) and germline BRCA 1/2 mutations: results from an international collaboration [abstract], Breast Cancer Res Treat, 82, S7
  9. Delaloge S, 2003, Young age is the major predictor of local relapse among conservatively treated BRCA1‐, BRCA2‐, or non‐BRCA‐linked hereditary breast cancer (BC) [abstract], Proc Am Soc Clin Oncol, 22, 11
  10. 10.1200/JCO.2004.04.033 · DOI · Paper page
  11. 10.1200/JCO.1999.17.10.3017 · DOI · Paper page
  12. Bremer M, 2003, Local relapse after post‐operative radiotherapy in patients with bilateral breast cancer by BRCA1/2 status [abstract], Proc Am Soc Clin Oncol, 22, 11
  13. 10.1016/j.ejca.2004.01.017 · DOI
  14. 10.1200/JCO.2002.02.026 · DOI · Paper page
  15. 10.1200/JCO.1998.16.6.2045 · DOI
  16. 10.1016/S0360-3016(00)00761-6 · DOI
  17. Haas JA, 1998, An analysis of age and family history on outcome after breast‐conservation treatment: the University of Pennsylvania experience, Cancer J Sci Am, 4, 308
  18. Harrold EV, 1998, Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history, Cancer J Sci Am, 4, 302
  19. Simmonds P, 1999, Is breast conservation appropriate for women with hereditary breast cancer [abstract]?, Proc Am Soc Clin Oncol, 18, 612a
  20. 10.1007/BF02557530 · DOI
  21. 10.1054/bjoc.2000.1239 · DOI · Paper page
  22. Foulkes WD, 1998, BRCA mutations and survival in breast cancer, J Clin Oncol, 16, 3206, 10.1200/JCO.1998.16.9.3206 · doi:10.1200/jco.1998.16.9.3206
  23. 10.1016/S0140-6736(05)79091-7 · DOI
  24. 10.1200/JCO.1998.16.5.1642 · DOI · Paper page

Cited by

Metadata

Authors
Robson, M., Svahn, T., McCormick, B., Borgen, P., A. Hudis, C., Norton, L., & Offit, K.
Venue
Cancer
Publisher
Wiley
Published
2004-11-22
Volume
103
Issue
1
Pages
44-51
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1995498471
Cited by
126
References
3
FWCI
5.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.